Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo
- PMID: 3292705
- DOI: 10.1111/j.1471-4159.1988.tb01084.x
Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo
Abstract
The concentration of luteinizing hormone releasing hormone (LHRH) (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2), which reaches the anterior pituitary via the hypothalamo-hypophyseal portal system, appears to be controlled in part by the rate of LHRH degradation within the hypothalamus and/or pituitary. Specific, active site-directed endopeptidase inhibitors synthesized in our laboratory were used to identify the enzyme(s) involved in LHRH degradation by hypothalamic and pituitary membrane preparations, and by an intact anterior pituitary tumor cell line (AtT20). Incubation of LHRH with pituitary and hypothalamic membrane preparations led to the formation of pGlu-His-Trp (LHRH1-3) as the main reaction product. Under the same conditions, addition to the incubation mixtures of captopril, an inhibitor of the angiotensin converting enzyme, led to accumulation of pGlu-His-Trp-Ser-Tyr (LHRH1-5) and, to a lesser extent, pGlu-His-Trp-Ser-Tyr (LHRH1-6). The degradation of LHRH and the formation of the N-terminal tri- and pentapeptides was blocked by N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate (cFP-AAF-pAB), a specific, active site directed inhibitor of endopeptidase-24.15. Some inhibition of LHRH degradation and formation of the N-terminal hexapeptide was also obtained in the presence of N-[1-carboxy-2-phenylethyl]-Phe-p-aminobenzoate (cFE-F-pAB), an inhibitor of endopeptidase-24.11. Similar results were obtained with AtT20 cell membranes and with intact AtT20 cells in monolayer culture. Following cleavage by endopeptidases the C-terminal part of LHRH was rapidly degraded by aminopeptidases. Superactive analogs of LHRH in which Gly6 was replaced by a D-amino acid are resistant to degradation by both endopeptidase-24.11 and -24.15. In vivo, when LHRH was injected directly into the third ventricle of rats, the presence of cFP-AAF-pAB inhibited LHRH degradation. It is concluded that LHRH degradation is primarily initiated by the membrane-bound form of endopeptidase-24.15 to yield pGlu-His-Trp-Ser-Tyr and to a lesser extent by endopeptidase-24.11 to yield pGlu-His-Trp-Ser-Tyr-Gly.
Similar articles
-
Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.J Pharmacol Exp Ther. 1989 Nov;251(2):439-47. J Pharmacol Exp Ther. 1989. PMID: 2681686
-
Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts.J Biol Chem. 1994 Apr 29;269(17):12626-32. J Biol Chem. 1994. PMID: 8175672
-
Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.Br J Pharmacol. 1996 Jul;118(5):1269-77. doi: 10.1111/j.1476-5381.1996.tb15533.x. Br J Pharmacol. 1996. PMID: 8818353 Free PMC article.
-
Is the metalloendopeptidase EC 3.4.24.15 (EP24.15), the enzyme that cleaves luteinizing hormone-releasing hormone (LHRH), an activating enzyme?Reproduction. 2010 Feb;139(2):319-30. doi: 10.1530/REP-09-0117. Epub 2009 Sep 15. Reproduction. 2010. PMID: 19755481 Review.
-
Luteinizing hormone-releasing hormone I (LHRH-I) and its metabolite in peripheral tissues.Exp Biol Med (Maywood). 2008 Feb;233(2):123-30. doi: 10.3181/0707-MR-201. Exp Biol Med (Maywood). 2008. PMID: 18222967 Review.
Cited by
-
Mapping sequence differences between thimet oligopeptidase and neurolysin implicates key residues in substrate recognition.Protein Sci. 2002 Sep;11(9):2237-46. doi: 10.1110/ps.0216302. Protein Sci. 2002. PMID: 12192079 Free PMC article.
-
Redox modulation of thimet oligopeptidase activity by hydrogen peroxide.FEBS Open Bio. 2017 Jun 19;7(7):1037-1050. doi: 10.1002/2211-5463.12245. eCollection 2017 Jul. FEBS Open Bio. 2017. PMID: 28680816 Free PMC article.
-
Pathways and kinetics of deslorelin degradation in an airway epithelial cell line (Calu-1).Pharm Res. 2003 May;20(5):779-87. doi: 10.1023/a:1023489620394. Pharm Res. 2003. PMID: 12751634
-
Comparative studies on the affinities of ATP derivatives for P2x-purinoceptors in rat urinary bladder.Br J Pharmacol. 1994 Aug;112(4):1151-9. doi: 10.1111/j.1476-5381.1994.tb13204.x. Br J Pharmacol. 1994. PMID: 7952876 Free PMC article.
-
Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs.AAPS J. 2015 Sep;17(5):1135-43. doi: 10.1208/s12248-015-9769-x. Epub 2015 May 9. AAPS J. 2015. PMID: 25956382 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous